Join us at the MarketsandMarkets 5th Industrial Revolution Roundtable on
20th June 2023 in San Jose, USA at the Park James Hotel. An exclusively curated, thought leadership forum hosted by Vinod Chikkareddy  (CCO, MarketsandMarkets) & Pranjal Sharma  (Author – The Next New), discussing recent trends & developments triggering the 5th Industrial Revolution & how organizations can demystify the resulting new $25 trillion B2B opportunity space!

Join us for this highly exclusive & hugely collaborative networking evening on
20th June 2023 in San Jose, USA at the Park James Hotel. Hosted by Vinod Chikkareddy  (CCO, MarketsandMarkets) with a special presentation on Decoding the $25 Trillion Global Business Transition by Pranjal Sharma  (Author – The Next New), the event explores potential roadmaps to harnessing market intelligence & gaining a tangible competitive advantage while ideating & implementing newer workflows & business models!

Our 6th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 22nd - 23rd June 2023, at Hilton Boston Logan Airport, Boston, would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

With the advent of new technological advancements in medical research and diagnostic strategies, early disease diagnosis and prevention has witnessed a medical revolution.

We are proud to present to you our ‘BioGene’ ConfEx in Boston scheduled on 22-23 June 2023 at Hilton Boston Logan Airport. This ConfEx is an assemblage of 3 inextricably linked conferences like Next-Gen Immuno-Oncology Conference, Biomarker and Companion Diagnostics and Single-Cell Omics Conference which will accommodate diverse sessions on cutting edge discussions via Presentations, Exhibitions, Speaker QnAs, Panel discussions or Breakout sessions.

The fundamentals of Single Cell have proven to be an indispensable resource in the sphere of medical research and new diagnostic strategies. Recent advances in single cell technologies have opened new opportunities to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option.

MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 22nd - 23rd June 2023 at Hilton Boston Logan Airport, Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.

Join us at the MarketsandMarkets 5th Industrial Revolution Roundtable on
23rd June 2023 in Chicago, USA at  Hotel EMC2, Autograph Collection. An exclusively curated, thought leadership forum hosted by Vinod Chikkareddy  (CCO, MarketsandMarkets) & Pranjal Sharma  (Author – The Next New), discussing recent trends & developments triggering the 5th Industrial Revolution & how organizations can demystify the resulting new $25 trillion B2B opportunity space!

Join us at the MarketsandMarkets 5th Industrial Revolution Roundtable on
27th June 2023 in NYC, USA at the NoMo Soho Hotel. An exclusively curated, thought leadership forum hosted by Vinod Chikkareddy  (CCO, MarketsandMarkets) & Pranjal Sharma  (Author – The Next New), discussing recent trends & developments triggering the 5th Industrial Revolution & how organizations can demystify the resulting new $25 trillion B2B opportunity space!

Real-world data and real-world evidence are poised to keep making strides in 2023. This analysis of clinical evidence studies the usage, potential advantages and risk of a medical product inferred from the real-world data analysis. Real-world evidence (RWE) is accelerating its involvement in the early benefit elucidation of medicinal drugs.

MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 5th-6th October 2023 in Frankfurt, Germany. This event is designed to provide forward-looking insights into the latest trends and tools impacting biomarker research, it brings together leading experts from global pharmaceutical organisations, innovative biotech companies and internationally renowned academic institutions working across multiple therapeutic areas and stages of drug development.

Over the past 6 years, Marketsandmarkets Next-Gen Immuno-Oncology conference has become the leading annual meeting focusing on the next wave of biotherapeutics, advances in technologies, and the valuable exchange of high-quality research from all disciplines of immuno-oncology. Marketsandmarkets IO congress provides access to a comprehensive 2-day program for participants to evaluate bi- or multi-specific biotherapeutics, explore the latest developments in existing and emerging cellular therapies, develop predictive preclinical models for translational strategies, appraise AI and computational tools for the discovery of new targets, target classes, and combinations to overcome resistance.

With the advent of neural implants and novel therapies, the cure of multiple neurodegenerative disorders proves wholesome for the patients’ suffering. Increasing in the severity of neurodegenerative diseases, demands the discovery of new translational approaches in neuroscience research.

With the enforcement of the 1983 Orphan Drug Act (ODA), manufacturers are obliged to scale production to treat rare/orphan diseases, leading to a drastic advancement in the landscape of orphan drugs. Novel therapies aimed at treating these uncommon diseases are paramount to fulfilling the unmet needs of patients.

The fundamentals of Single Cell have proven to be an indispensable resource in the sphere of medical research and new diagnostic strategies. Recent advances in single cell technologies have opened new opportunities to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option.

MarketsandMarkets is proud to announce the 6th Annual Real-World Evidence and Life Sciences Conference to be held on October 16th - 17th, 2023 in Boston, USA.

Real-world data and real-world evidence are poised to keep making strides in 2023.
The emergence of this pandemic has posed severe financial constraints on pharma-biopharma companies in several countries. In this regard, RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting to organize and evaluate clinical data for regulatory submissions.

In recent years, digital pathology has become a well-established technology. Globally focused on education, tissue-based research, medication development, and human pathology practice.

The Diagnostics sector has emerged as a prominent game changer in healthcare, because of many technological advancements taking place within the field. As diagnostics is a key to making treatment decisions, it needs to be quicker, more precise, and more accurate.

Looking and the current market scenario, many companies are outsourcing the manufacture of their highly potent compounds for various reasons, mainly marketing. The escalation in the High Potent drug market is subjected to a variety of aspects such as the diversification of pharmaceutical manufacturers towards precision medicines such as HPAPI, increasing demand for oncology drugs & antibody-drug conjugates, and advancements in HPAPI manufacturing technologies.

Traditionally, pharmaceutical companies have relied on long product lifecycles to enable the development of more efficient processes and the introduction of technological. Innovation happens at a slower pace compared to other manufacturing sectors. Nevertheless, the third decade of the 21st century brings about some key market transitions, including regulatory and production challenges that need to be managed. This is to ensure competitiveness, growth, and profitability are maintained.

Agriculture is a major economic sector for any country.  It is integral to our very existence. Emerging trends in Agriculture are one of the primary drivers of the sector's expansion. Emerging agricultural trends involve new technologies and strategies that become more advanced over time. There have been significant changes in the agriculture sector over the past several decades and new technologies have also been introduced. All these factors have led to an expansion of the sector. Recent agricultural advances have made farming activities more comfortable and acceptable for farmers. Developments or trends such as these benefit not only the growth of agriculture, but also the lives of farmers. 

Plant-based foods are one of the fastest growing food categories, growing by double digits since 2019, and are expected to reach $68.4 billion worldwide by 2026. The growth of this market is driven by a wide range of factors, including the increasing intolerance for animal proteins among consumers, the growing vegan population, and the booming number of venture investments in plant-based foods. Further, the increasing number of new products developed by manufacturers of plant-based proteins and emerging economies, such as Asian-Pacific, Latin America, and Middle East & Africa, are expected to provide new opportunities for players in this market.

With the advent of new technological advancements and surgical techniques, minimally invasive surgery has witnessed a robotic revolution in the field of surgery in the form of Da Vinci robotic systems making MIS procedures a widely accepted standard of care for most of the clinical specialities all over the world. We are proud to present to you our 3rd Annual MarketsandMarkets Minimally Invasive Surgery Conference (3 streams) in London, scheduled on 21st - 22nd March 2023.

MarketsandMarkets is proud to announce it’s 8th Annual Infection Control, Sterilization & Decontamination in Healthcare Conference scheduled for 21st - 22nd March 2024 in London, UK.

This Congress aims to bring together all the stakeholders, to discuss the challenges in achieving and maintaining an infection free environment in the hospital settings in addition to effective and evidence based ways to reduce the risks of the emergence of healthcare-associated infections through fomites and medical equipment because of substandard infection prevention and control practice and contaminated medical devices.